Exelixis Inc (EXEL) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access EXEL quarterly Cash Flow →
Looking at cash flow data from Exelixis Inc through Dec 31 2021 provides insight into Jan 02 2026's financial flexibility across reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Jan 02 2026)
12 Months
(Jan 03 2025) (Dec 29 2023) (Dec 30 2022) (Dec 31 2021)
Operating Activities
Income782.57
Depreciation & amortization29.06
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring Costs and Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories12.23
Research and Development in Process0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation112.98
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Increase Decrease In Operating Lease Right of Use Asset-
Increase Decrease Accrued Clinical Liabilities-
Increase Decrease In Rebates And Fees Payable-
Increase Decreasein Accrued Collaboration Liability-
Increase Decrease In Contract With Customer Liability-
Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash-
Noncash Lease Expense24.23
Research And Development Asset Acquired Other Than Through Business Combination Written Off12.00
Income taxes0.00
Gain (Loss) on Sale of Other Investments0.00
Increase (Decrease) in Accounts Receivable-21.40
Increase (Decrease) in Accounts Payable-50.15
Increase (Decrease) in Accrued Liabilities1.90
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-7.53
Other Working Capital0.00
Other Noncash Income (Expense)-11.61
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities884.27
Investing Activities
Capital Expenditures-8.43
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities1,022.87
Payments to Acquire Marketable Securities-632.50
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development-31.50
Proceeds from Sale of Equity Method Investments0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities350.44
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-898.37
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-288.59
Proceeds From Exercise Of Stock Options And Warrants-
Repayments Net From Deconsolidation Of Company-
Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases-
Payments for Conversion of Convertible Debt-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents217.37
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-969.59
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow875.84
Total Cash Flow265.11
4 historic quarters locked

Sign in to unlock the full Exelixis Inc cash flow history.

About Exelixis Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20260102)
  • Filed with the SEC: February 10, 2026
  • Source: exel-20260102.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000939767-26-000021

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License